Culver City, CANCT05432466Now EnrollingIRB Ready

Vascular Ehlers-Danlos Syndrome Clinical Trial in Culver City, CA

Access cutting-edge vascular ehlers-danlos syndrome treatment through this phase 3 clinical trial at a research site in Culver City. Study-provided care at no cost to qualified participants.

Sponsored by Acer Therapeutics Inc.

Quick Self-Assessment

See if you qualify for this Culver City location

Preparing your pre-screening questions…

Expert Care in Culver City

Access vascular ehlers-danlos syndrome specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related vascular ehlers-danlos syndrome treatment provided free

Apply for This Culver City Location

Check if you qualify for this vascular ehlers-danlos syndrome clinical trial in Culver City, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Culver City

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Culver City site if eligible
  4. 4Begin participation

About This Vascular Ehlers-Danlos Syndrome Study in Culver City

This is a prospective, Phase 3, randomized, double-blind, placebo-controlled efficacy study to evaluate celiprolol in patients genetically confirmed as COL3A1-positive vEDS using a decentralized clinical trial design.

Sponsor: Acer Therapeutics Inc.

Who Can Participate

Inclusion Criteria

Willingness to obtain magnetic resonance angiogram (MRA) image at local imaging facility.
A genetic test confirming the presence of a pathogenic COL3A1 variant (classified as likely pathogenic or pathogenic according to ACMG/AMP Guidelines.
Patients must be ≥ 15 years of age at the time of randomization.
Able and willing to discontinue use of β-blockers prior to randomization.

Exclusion Criteria

Lack of a COL3A1-positive test at screening (e.g., COL3A1 benign, likely benign, variant of unknown significance \[VUS\] or no variant) or presence of a COL3A1 variant but demonstration of a COL3A1 variant reported to be a haploinsufficiency variant.
Arterial rupture or dissection, uterine rupture, and/or intestinal rupture within 6 months prior to Screening.
Patients unable to discontinue β-blocker treatment prior to randomization.
Unable or unwilling to complete the study procedures.
Breastfeeding, pregnancy, or planned pregnancy during the trial.
Any medical condition that in the opinion of the Investigator may pose a safety risk to the patient in this study, which may confound efficacy or safety assessment, or may interfere with study participation.
Use of any prohibited medications

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Culver City?

Yes, this clinical trial (NCT05432466) has an active research site in Culver City, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Vascular Ehlers-Danlos Syndrome Treatment Options in Culver City, CA

If you're searching for vascular ehlers-danlos syndrome treatment options in Culver City, CA, this clinical trial (NCT05432466) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Culver City research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced vascular ehlers-danlos syndrome specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all vascular ehlers-danlos syndrome clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Culver City, CA

See all ankylosing spondylitis clinical trials recruiting in Culver City — not just this study.

Browse Ankylosing Spondylitis Trials in Culver City →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsEhlers-Danlos Syndrome TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Culver City?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Culver City, CA